Exfoliative dermatitis
☆ AI Dermatology — Free Service
Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
Red (burning) Skin Syndrome — erythema uye chikero pamuviri wese ndizvo zviratidzo zvikuru zve Exfoliative dermatitis.
relevance score : -100.0%
ReferencesErythroderma isingawanzo asi mamiriro akakomba eganda. Kunyange zvazvo chikonzero chaicho chisiri kuzivikanwa kazhinji, chinogona kukonzerwa nekushandisa zvinodhaka kana kenza iri pasi. Imwe kenza yakajairika inobatana ne exfoliative dermatitis i cutaneous T-cell lymphoma, iyo inogona kusaratidza zviratidzo kwemwedzi kana makore mushure mekutanga kwechirwere cheganda. Kazhinji, kuongororwa kwekutanga uye kurapwa kunodiwa kuchipatara. Varwere vane chirwere chinokonzerwa nezvinodhaka kazhinji vane maonero akanaka kwenguva refu, kunyange zvazvo nyaya dzisina chikonzero chakajeka dzinowanzoda nzira inodzokororwa uye yekudzorera. Kufanotaura kwezviitiko zvine chekuita ne gomarara kazhinji zvinoenderana nekuti cancer inofamba sei.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Inowanzo ratidza kutsvuka kwakapararira uye kuputika kunofukidza pamusoro pe90% yemutumbi. Ichi chiratidzo chinooneka chezvirwere zvakasiyana-siyana zvinobatanidza sepsoriasis, eczema, kana mhinduro kumishonga.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Chinonyanya kukonzera erythroderma ndiko kuwedzera kwechirwere cheganda chepasi, chakadai se psoriasis, contact dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris, kana kushandiswa kwezvinodhaka zvakadai sekushandisa topical steroids. Primary manifestation haina kuwanda uye inowanzoonekwa muzviitiko zve cutaneous T‑cell lymphoma. Nokuti zvakakosha kuisiyanisa kubva ku cutaneous T‑cell lymphoma, biopsy inoitwa.